TMJ Disc Regeneration
- Institution
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- Principal investigator
- Alejandro Jose Almarza
- Funding
- $338K
- Duration
- 2024–2028
Moonbase score
Still being scored
Abstract
Patients opting for TMJ disc removal face issues due to the absence of FDA-approved replacements, leading to bone-to-bone contact and subsequent joint problems. Autografts, like dermis-fat grafts, typically resorb within a year. Our goal is a secure disc replacement alternative. Previous studies demonstrated rapid transformation of an acellular ECM scaffold into TMJ disc-like tissue in canine and porcine models. The canine model, chosen for its hinge- socket preventing implant migration, lacks human-like motions, and pig models have access issues. Introducing the goat model, with human-like access and motions, addresses these limitations. Proposed research focuses on the 12-month clinical endpoint, investigating the impact of a pathogenic TMJ environment on remodeling a porcine SIS scaffold into a neo-disc in goats. We aim to determine the long-term (6, 9, 12 months) functional remodeling of SIS scaffolds in the TMJ, hypothesizing higher tensile moduli than dermis-fat autografts, even in a pathological environment. Addressing a critical gap in understanding outcomes beyond 6 months is crucial for clinical translation. This work aims to provide a groundbreaking, safe TMJ disc treatment, preventing joint damage and revolutionizing surgical management for TMJ patients, with the potential to significantly improve outcomes.
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Pittsburgh at PittsburghNot yet scored
Collaborative for REsearch to AdvanceTMD Evidence (CREATE)
Alejandro Jose Almarza · $3.5M · 2025–2030
- NIH · University of Pittsburgh at PittsburghNot yet scored
Administrative Core
Alejandro Jose Almarza · $869K · 2025–2030
- NIH · University of Pittsburgh at Pittsburgh64
Core E: Omics Core
Sid E O'Bryant · $3.2M · 2020–2026